Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates

Screening of the novel antimicrobial drug, XF-73, against 2,527 Staphylococcus species clinical isolates

XF-73 (exeporfinium chloride) is a synthetic, di-cationic porphyrin derivative with rapid, potent bactericidal properties and a low propensity for engendering bacterial resistance. It is being developed clinically for the decolonization of Staphylococcus aureus in the nasal cavity to prevent post-op...

Full description

Bibliographic Details
Main Authors: William Rhys-Williams, Helen Marie Galvin, William Guy Love
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-10-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
exeporfinium chloride
XF-73
Staphylococcus aureus
MRSA
Staphylococcus species
MIC
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2023.1264456/full

Similar Items

Similar Items